Drug intelligence / Profile preview

yiqi yangxue formula

Development stage
Unknown
Lead developer
Ruihui Pharmaceutical
Administration
Oral
01

Overview

**Yiqi Yangxue formula** is a prescribed **Chinese herbal medicine** formulation used primarily for the treatment of knee osteoarthritis (KOA) and investigated for liver fibrosis and chronic hepatitis B cirrhosis[1][3][4][5]. Its formula contains botanicals such as astragalus, codonopsis, tangerine peel, cohosh, bupleurum, angelica, cassia twig, white peony, atractylodes, licorice, divaricate saposhniovia root, ligusticum wallichii, rhizoma drynariae, and epimedium[4]. Mechanistically, Yiqi Yangxue formula acts by inhibiting cartilage degeneration through regulating the lncRNA-UFC1/miR-34a/MMP-13 axis, thus inhibiting cell apoptosis, promoting cell proliferation, and reducing inflammatory mediators. The in vivo active constituents include flavonoids (quercetin, fisetin) and phenylpropanoids (demethylweldelolactone); relevant pathways are IL-17, TNF signaling, relaxin, and C-type lectin receptor signaling[1][4][5]. It demonstrated a high total effective rate for KOA (96.67% in one clinical study), with comparable or fewer adverse effects than standard therapy[4]. For decompensated hepatitis B cirrhosis, combination therapy with entecavir improved liver function markers and reduced fibrosis, with good safety[3].

Brand names
Yiqi Yangxue formula
Other names
YQYXF
02

Targets

MMP13 (Matrix metalloproteinase-13)ADAMTS5 (A disintegrin and metalloproteinase with thrombospondin motifs 5)

Beyond the preview

Go deeper on yiqi yangxue formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiqi yangxue formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call